BioForm Medical Inc. is a medical aesthetics company headquartered in San Mateo California. BioForm Medical is dedicated to bringing doctors and their patients safe and effective products for use in the dermatology plastic surgery and ENT markets. BioForm Medical's products include Radiesse dermal filler for use in facial aesthetics and vocal fold insufficiency and Coaptite injectable implant for treating female stress urinary incontinence which is marketed through a partnership with Boston Scientific Corporation. BioForm Medical has licensed U.S. marketing rights to Aethoxysklerol sclerotherapy agent which is the leading worldwide sclerotherapy agent and is currently being evaluated in a Phase III clinical trial. BioForm Medical has also licensed BioGlue surgical adhesive product for plastic surgery applications which is being developed in a partnership with CryoLife Inc. Bioform Medical Inc. has a market cap of $180.7 million; its shares were traded at around $3.89 with and P/S ratio of 2.8.
Insiders' Positions with BFRM
- Sell:: SVP, Corporate Development Adam Gridley sold 33,438 shares of BFRM stock on 08/25/2009 at the average price of 2.87, the price of the stock has increased by 35.54% since
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |